Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6

Jonathan S Gootenberg,Omar O Abudayyeh,Max J Kellner,Julia Joung,James J Collins,Feng Zhang,Jonathan S. Gootenberg,Omar O. Abudayyeh,Max J. Kellner,James J. Collins

DOI: https://doi.org/10.1126/science.aaq0179

IF: 56.9

2018-04-27

Science

Abstract:Taking CRISPR technology further CRISPR techniques are allowing the development of technologies for nucleic acid detection (see the Perspective by Chertow). Taking advantages of the distinctive enzymatic properties of CRISPR enzymes, Gootenberg et al. developed an improved nucleic acid detection technology for multiplexed quantitative and highly sensitive detection, combined with lateral flow for visual readout. Myhrvold et al. added a sample preparation protocol to create a field-deployable viral diagnostic platform for rapid detection of specific strains of pathogens in clinical samples. Cas12a (also known as Cpf1), a type V CRISPR protein, cleaves double-stranded DNA and has been adapted for genome editing. Chen et al. discovered that Cas12a also processes single-stranded DNA threading activity. A technology platform based on this activity detected human papillomavirus in patient samples with high sensitivity. Science , this issue p. 439 , p. 444 , p. 436 ; see also p. 381

multidisciplinary sciences

What problem does this paper attempt to address?

This paper aims to address the limitations of the existing CRISPR - Cas13 - based nucleic acid detection technology (SHERLOCK) in multi - target detection, quantitative measurement, signal sensitivity, and portable detection methods. Specifically:

1. **Multi - target detection**: The existing SHERLOCK technology can only detect a single target molecule, while many application scenarios require the detection of multiple target molecules in the same reaction. Therefore, researchers are committed to developing a technology platform that can detect multiple target molecules simultaneously.

2. **Quantitative measurement**: The existing SHERLOCK technology lacks accurate quantitative capabilities, especially in the detection of low - concentration samples. Researchers hope to improve the quantitative measurement accuracy of this technology for input samples, enabling it to detect target molecules at extremely low concentrations.

3. **Signal sensitivity**: To improve the detection sensitivity, researchers have explored methods of combining other CRISPR - related enzymes (such as Csm6) to enhance signal strength and detection speed.

4. **Portable detection methods**: Existing technologies rely on fluorescence detection equipment, which limits their application in resource - limited environments. Researchers have developed a visual read - out method based on lateral flow strips, making the detection process free of additional instruments and more suitable for on - site rapid detection.

Through these improvements, researchers hope to develop the SHERLOCK technology into a more versatile, sensitive, portable, and applicable nucleic acid detection platform for multiple scenarios.